Residency · Houston, TX
Sponsored by University of Texas Health Science Center at Houston
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.
JAMA · 2024 · 690 citations · Deborah Horn
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
The New England journal of medicine · 2025 · 427 citations · Deborah Horn
EACTS/STS Guidelines for Diagnosing and Treating Acute and Chronic Syndromes of the Aortic Organ.
The Annals of thoracic surgery · 2024 · 257 citations · Anthony Estrera
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Lancet (London, England) · 2025 · 275 citations · Mark Ghobrial
Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022 · 444 citations · Nancy Perrier
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.
Nature medicine · 2024 · 266 citations ·
Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial.
JAMA surgery · 2022 · 394 citations · Mark Ghobrial
Assessing the Accuracy of Responses by the Language Model ChatGPT to Questions Regarding Bariatric Surgery.
Obesity surgery · 2023 · 209 citations · Lauren Hawley